Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules Synthetic biology startup Cambrium announces €8 Million in Seed financing, led by Essential Capital, along with SNR, Valor Equity Partners, and HOF Capital

Cambrium Launches NovaColl™: First Micro-Molecular & Skin-Identical Collagen Ingredient for Personal Care Industry BERLIN, March 23, 2023 (GLOBE NEWSWIRE) -- Biotechnology company Cambrium has launched its first product: NovaColl™. It is the first micro-molecular & 100% skin-identical collagen specifically...